Wang Yan, Li Yingbo, Di Chen, Liu Tu, Hou Qianlin, Wang Shali
Institute of Neuroscience, Basic Medical College, Chongqing Medical University, Chongqing, People's Republic of China.
Neuroreport. 2016 Sep 28;27(14):1072-80. doi: 10.1097/WNR.0000000000000659.
Hypoxic-ischemic encephalopathy (HIE) is a serious clinical problem, responsible for many cases of motor impairment, cognitive deficits, and mortality. Transient receptor potential canonical (TRPC) channels are nonselective cation channels that play a role in many disorders, including trauma, pulmonary hypertension, and excitotoxicity. However, the properties and underlying mechanisms of TRPC channels in HIE are still controversial. Extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin (mTOR) are central signaling pathways that transmit signals from extracellular to intracellular agents and mediate prosurvival, proliferation, and motility proteins. The relationship between TRPC channels, ERK, and mTOR is unclear. We used oxygen-glucose deprivation/reoxygenation in primary cortical neurons and PC12 cells to mimic an HIE episode. The potential effects and mechanisms of TRPC channels were examined. MNC (M: MK-801; N: nimodipine; C: CNQX) were used to exclude the interference of N-methyl-D-aspartate receptors, AMPK receptors, and calcium channels. We administered TRPC inhibitor SKF96365 to the cells, and then measured cell apoptosis and expression of ERK and mTOR signal pathways. At the same time, an ERK inhibitor or an mTOR agonist was used to further ensure the relation between TRPC channels and ERK, mTOR. Results showed that hypoxia-ischemia clearly induced cell apoptosis, activated the ERK pathway, and suppressed the mTOR pathway. Blocking of TRPC channels could enhance hypoxia-ischemia-induced apoptosis and lead to increased p-ERK pathway activity and decreased p-mTOR pathway activity. However, the ERK inhibitor or the mTOR agonist could reverse the effect of SKF96365. This study suggests that TRPC channels may be an effective treatment for HIE, regulating the ERK and mTOR pathways.
缺氧缺血性脑病(HIE)是一个严重的临床问题,导致许多运动障碍、认知缺陷和死亡病例。瞬时受体电位经典型(TRPC)通道是非选择性阳离子通道,在包括创伤、肺动脉高压和兴奋性毒性在内的许多疾病中起作用。然而,TRPC通道在HIE中的特性和潜在机制仍存在争议。细胞外信号调节激酶(ERK)和雷帕霉素哺乳动物靶蛋白(mTOR)是将信号从细胞外传递到细胞内因子并介导促生存、增殖和运动蛋白的核心信号通路。TRPC通道、ERK和mTOR之间的关系尚不清楚。我们在原代皮层神经元和PC12细胞中使用氧糖剥夺/复氧来模拟HIE发作。研究了TRPC通道的潜在作用和机制。使用MNC(M:MK-801;N:尼莫地平;C:CNQX)来排除N-甲基-D-天冬氨酸受体、AMPK受体和钙通道的干扰。我们将TRPC抑制剂SKF96365应用于细胞,然后测量细胞凋亡以及ERK和mTOR信号通路的表达。同时,使用ERK抑制剂或mTOR激动剂来进一步确定TRPC通道与ERK、mTOR之间的关系。结果表明,缺氧缺血明显诱导细胞凋亡,激活ERK通路,并抑制mTOR通路。阻断TRPC通道可增强缺氧缺血诱导的凋亡,并导致p-ERK通路活性增加和p-mTOR通路活性降低。然而,ERK抑制剂或mTOR激动剂可逆转SKF96365的作用。本研究表明,TRPC通道可能是治疗HIE的有效方法,可调节ERK和mTOR通路。